- Cannara Biotech press release (OTCQB:LOVFF): Q1 GAAP EPS of C$0.03.
- Revenue of C$25.1M (+28.7% Y/Y).
- Gross cannabis revenues increased by 33% to C$34.9 million in Q1 2025, up from C$26.3 million in Q1 2024.
- Delivered fifteenth consecutive quarter of positive Adjusted EBITDA, generating a company record of C$6.0 million, in addition to record-high operating cash flow of C$5.8 million, compared to C$0.8 million in Q1 2024, and record free cash flow, of C$4.6 million compared to C$(2.0) million in Q1 2024.